In this study, we aimed to explore the molecular and cellular characteristics associated with FOXA1 mutant prostate cancer and identify potential therapeutic targets and candidate drugs that may hold promise for improved treatment approaches. This evidence concerns the gene FOXA1 and prostate cancer.